S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Aastrom Biosciences, Inc. Announces Pricing of Public Offering of Common Stock and Warrants (2013/8/13)|
|Aastrom Biosciences Announces Amendment of Series B Preferred Stock Certificate of Designations, Preferences and Rights (2013/8/12)|
|Aastrom Biosciences, Inc. Announces Closing of Public Offering of Common Stock and Warrants (2013/8/16)|
|Heidi Hagen Joins Aastrom Board of Directors (2013/8/26)|
|Aastrom Clinical Trial Application for Phase 2b ixCELL-DCM Study of ixmyelocel-T Approved in Canada (2013/9/16)|
|Aastrom Biosciences to Present at the Aegis Capital 2013 Healthcare Conference (2013/9/19)|
|Aastrom Biosciences to Present at the 2013 Stem Cell Meeting on the Mesa Conference (2013/10/10)|
|Aastrom Biosciences One-for-Twenty Reverse Stock Split Now Effective (2013/10/16)|
|Aastrom Announces Results of Two Studies of Ixmyelocel-T Published in Stem Cell Research & Therapy (2013/11/1)|
|Aastrom Biosciences Regains Compliance With NASDAQ Minimum Bid Requirement ()|
Click above to view more mutual fund data and stats for 8881 - Nisshin Fudosan Co Ltd.